Sebastien BAZIN

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London, Sébastien Bazin was appointed CEO of Hottinguer Rivaud Finances, an investment bank, in 1990, and then CEO of L’Immobilière Hôtelière, a hotel developer in France, in 1992. In 1997, he moved to Colony Capital, a private real estate investment firm, to head up its European branch and lead several acquisitions, principally in the hospitality sector (Générale des Eaux, Club Méditerranée, Lucien Barrière, Fairmont & Raffles, Buffalo Grill, Château Lascombes, Stadia Consulting and others). He joined Accor’s Board of Directors in 2005 and, via Colony Capital, became a Paris Saint-Germain shareholder in 2006 and the club’s Chairman in 2009. In August 2013, he resigned from his duties at Colony Capital and was appointed Chairman and CEO of Accor. Sébastien Bazin is President of the Gustave Roussy Foundation’s Board of Directors since July 2023, and has been a member of GE’s Board of Directors since 2016. In January 2023, in addition to his current role as Group Chairman & CEO, he also took under his leadership the Group’s Luxury & Lifestyle division as division CEO.

PEGASCY governance

Founders

MD, phD
 

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy

Jean-Charles

SORIA

Chief Executive Officer
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

MD, phD
 

Fabrice André: Director of Research at Gustave Roussy since February 2020, Prof. Fabrice André coordinates the Institute's medical-scientific research programs, in conjunction with the Medical Director.

Fabrice

ANDRÉ

 

MD, phD
 

Aurelie Marabelle: MD, PhD, is a Senior Medical Oncologist in the Drug Development Department (DITEP), a group leader in Prof Laurence Zitvogel’s lab (INSERM U1015)

Aurélien

MARABELLE

MBA
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sébastien

BAZIN

MBA
 

Thierry Bruhat: he spent more than 20 years in supporting innovation projects and policies based on cooperation between companies, research

Thierry

BRUHAT

Board

Chairman
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

Censor
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sebastien

BAZIN

Directors
 

Fabrice Barlesi: As a specialist in lung cancer, precision medicine and cancer immunology

Fabrice

BARLESI

Directors
 

Olivier Edwards: is a lawyer who advises emerging companies and venture capital funds on investment, merger & acquisition matters with an emphasis on cross-border deals.

Olivier

EDWARDS

COO/CFO
 

Jean-Paul Alves, BSc in Economy, Graduated from EM Lyon and Post Graduated in Managerial Accounting, Chartered Accounting and Tax, joined Pegascy in 2020 as Chief Financial Officer.

Jean-Paul

ALVES